Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Other Non-Current Assets (2023 - 2025)

Beta Bionics' Other Non-Current Assets history spans 3 years, with the latest figure at $180000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 80.0% year-over-year to $180000.0; the TTM value through Dec 2025 reached $180000.0, up 80.0%, while the annual FY2025 figure was $180000.0, 80.0% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $180000.0 at Beta Bionics, down from $183000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $183000.0 in Q3 2025 and bottomed at $100000.0 in Q4 2024.
  • The 3-year median for Other Non-Current Assets is $146000.0 (2025), against an average of $146000.0.
  • The largest annual shift saw Other Non-Current Assets decreased 17.36% in 2024 before it skyrocketed 80.0% in 2025.
  • A 3-year view of Other Non-Current Assets shows it stood at $121000.0 in 2023, then fell by 17.36% to $100000.0 in 2024, then surged by 80.0% to $180000.0 in 2025.
  • Per Business Quant, the three most recent readings for BBNX's Other Non-Current Assets are $180000.0 (Q4 2025), $183000.0 (Q3 2025), and $146000.0 (Q1 2025).